Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 577-598 , December 2006

Androgen resistance

  • Ieuan A. Hughes (Professor, Head of Department of Paediatrics)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 1223 336885; Fax: +44 1223 336996.

References 

  1. Morris JM. The syndrome of testicular feminization in male pseudohermaphrodites. American Journal of Obstetrics and Gynecology. 1953;65:1192–1211
  2. Wilkins L. Heterosexual development. In: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. Springfield, IL: Charles C Thomas; 1950;p. 256–279
  3. Zhan Y, Fujino A, MacLaughlin DT, et al. Mullerian inhibiting substance regulates its receptor/SMAD signalling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development. 2006;133:2359–2369
  4. Josso N, Belville C, di Clemente N, et al. AMH and AMH receptor defects in persistent Mullerian duct syndrome. Human Reproduction Update. 2005;11:351–356
  5. Hutson JM, Hasthorpe S. Testicular descent and cryptorchidism: the state of the art in 2004. Journal of Pediatric Surgery. 2005;40:297–302
  6. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–839
  7. Heinlein CA, Chang C. Androgen receptor (AR) coregulators: an overview. Endocrine Reviews. 2002;23:175–200
  8. Bevan CL, Hoare S, Claessens F, et al. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Molecular and Cellular Biology. 1999;19:8383–8392
  9. Tut TG, Ghadessy FJ, Trifiro MA, et al. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. The Journal of Clinical Endocrinology and Metabolism. 1997;82:3777–3782
  10. Cheung-Flynn J, Prapapanich V, Cox MB, et al. Physiological role for the cochaperone FKBP52 in androgen receptor signalling. Molecular Endocrinology (Baltimore, Md.). 2005;19:1654–1666
  11. Matias PM, Donner P, Coelho R, et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. The Journal of Biological Chemistry. 2000;275:26164–26171
  12. Sack JS, Kish KF, Wang C, et al. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:4904–4909
  13. Banksboll S, Qvist I, Lebech PE, et al. Testicular feminization syndrome and associated gonadal tumours in Denmark. Acta Obstetricia et Gynecologica Scandinavica. 1992;71:63–66
  14. Boehmer AL, Brinkmann AO, Bruggenwirth H, et al. Genotype versus phenotype in families with androgen insensitivity syndrome. The Journal of Clinical Endocrinology and Metabolism. 2001;86:4151–4160
  15. Deeb A, Hughes IA. Inguinal hernia in female infants: a cue to check the sex chromosomes?. BJU International. 2005;96:401–403
  16. Michailidis GD, Papageorgiou P, Morris RW, et al. The use of three-dimensional ultrasound for fetal gender determination in the first trimester. The British Journal of Radiology. 2003;76:448–451
  17. Hughes IA, Houk C, Ahmed SF, et al. Consensus statement on management of intersex disorders. Archives of Disease in Childhood. 2006;91:554–563
  18. Yong EL, Loy CJ, Sim KS. Androgen receptor gene and male infertility. Human Reproduction Update. 2003;9:1–7
  19. Gottlieb B, Lombroso R, Beitel LK, et al. Molecular pathology of the androgen receptor in male (in)fertility. Reproductive Biomedicine Online. 2005;10:42–48
  20. Ahmed SF, Cheng A, Hughes IA. Assessment of the gonadotropin-gonadal axis in androgen insensitivity syndrome. Archives of Disease in Childhood. 1999;80:324–329
  21. Sinnecker G, Kohler S. Sex hormone-binding globulin response to the anabolic steroid stanazolol: evidence for its suitability as a biological androgen sensitivity test. The Journal of Clinical Endocrinology and Metabolism. 1989;68:1195–1200
  22. Sinnecker GH, Hiort O, Nitsche EM, et al. Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. European Journal of Pediatrics. 1997;1:7–14
  23. Corbier P, Edwards DA, Roffi J. The neonatal testosterone surge: a comparative study. Archives internationales de physiologie, de biochimie et de biophysique. 1992;100:127–131
  24. Boas M, Boisen KA, Virtanen HE et al. Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys. European Journal of Endocrinology 2006; 154: 125–129.
  25. Main KM, Schmidt IM, Skakkebaek NE. A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak. The Journal of Clinical Endocrinology and Metabolism. 2000;85:4905–4907
  26. Brown GR, Nevison CM, Fraser HM, et al. Manipulation of post-natal testosterone levels affects phallic and clitoral development in infant rhesus monkeys. International Journal of Andrology. 1999;22:119–128
  27. Mann DR, Gould KG, Collins DC, et al. Blockade of neonatal activation of the pituitary-testicular axis: effect on peripubertal luteinising hormone and testosterone secretion and on testicular development in male monkeys. The Journal of Clinical Endocrinology and Metabolism. 1989;68:600–607
  28. Bouvattier C, Carel JC, Lecointre C, et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. The Journal of Clinical Endocrinology and Metabolism. 2002;87:29–32
  29. Quigley CA. Editorial: the postnatal gonadotropin and sex steroid surge – insights from the androgen insensitivity syndrome. The Journal of Clinical Endocrinology and Metabolism. 2002;87:24–28
  30. Bergada I, Milani C, Bedecarras P, et al. Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. The Journal of Clinical Endocrinology and Metabolism. 2006;91:4092–4098
  31. Rey RA, Belville C, Nihoul-Fekete C, et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimullerian hormone measurement. The Journal of Clinical Endocrinology and Metabolism. 1999;84:627–631
  32. Arlt W, Walker EA, Draper N, et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet. 2004;363:2128–2135
  33. Miller WL. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology. 2005;146:2544–2550
  34. Huang N, Pandey AV, Agrawal V, et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. American Journal of Human Genetics. 2005;76:729–749
  35. Hughes IA, Evans BAJ. The fibroblast as a model for androgen resistant stages. Clinical Endocrinology. 1988;28:565–579
  36. Shkolny DL, Beitel LK, Ginsberg J, et al. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively. The Journal of Clinical Endocrinology and Metabolism. 1999;84:805–810
  37. Gottlieb B, Beitel LK, Wu JH, Trifiro M. The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat. 2004;23:527–533
  38. Radmayr C, Culig Z, Glatzl J, et al. Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome. The Journal of Urology. 1997;158:1553–1556
  39. Deeb A, Mason C, Lee YS, et al. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clinical Endocrinology. 2005;63:56–62
  40. de Sanctis L, Delmastro L, Russo MC, et al. Genetics of McCune-Albright syndrome. Journal of Pediatric Endocrinology & Metabolism. 2006;19(supplement 2):577–582
  41. Hiort O, Sinnecker GH, Holterhus PM, et al. Inherited and de novo androgen receptor gene mutations: investigation of single-case families. The Journal of Pediatrics. 1998;132:939–943
  42. Kohler B, Lumbroso S, Leger J, et al. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counselling. The Journal of Clinical Endocrinology and Metabolism. 2005;90:106–111
  43. Boehmer AL, Brinkmann AO, Nijman RM, et al. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. The Journal of Clinical Endocrinology and Metabolism. 2001;86:1240–1246
  44. Holterhus PM, Werner R, Hoppe U, et al. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. Journal of Molecular Medicine. 2005;83:1005–1113
  45. He B, Kemppainen JA, Wilson EM. FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. The Journal of Biological Chemistry. 2000;275:22986–22994
  46. Quigley CA, Tan JA, He B, et al. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction. Mechanisms of Ageing and Development. 2004;125:683–695
  47. He B, Gampe RT, Hnat AT, et al. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity. The Journal of Biological Chemistry. 2006;281:6648–6663
  48. Jääskeläinen J, Deeb A, Schwabe JW, et al. Human androgen receptor gene ligand-binding domain mutations leading to disrupted interaction between the N- and C-terminal domains. Journal of Molecular Endocrinology. 2006;36:361–368
  49. Mongan NP, Lim HN, Hughes IA. Genetic evidence to exclude the androgen receptor-polyglutamine associated coactivator, ARA-24, as a cause of male undermasculinisation. European Journal of Endocrinology. 2001;145:809–811
  50. Lim HN, Hawkins JR, Hughes IA. Genetic evidence to exclude the androgen receptor co-factor, ARA70 (NCOA4) as a candidate gene for the causation of undermasculinised genitalia. Clinical Genetics. 2001;59:284–286
  51. Xu J, Liao L, Ning G, et al. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:6379–6384
  52. Mongan NP, Jääskeläinen J, Bhattacharyya S, et al. Steroid receptor coactivator-3 glutamine repeat polymorphism and the androgen insensitivity syndrome. European Journal of Endocrinology. 2003;148:277–279
  53. Adachi M, Takayanagi R, Tomura A, et al. Androgen-insensitivity syndrome as a possible coactivator disease. The New England Journal of Medicine. 2000;343:856–862
  54. Hughes IA. A novel explanation for resistance to androgens. The New England Journal of Medicine. 2000;343:881–882
  55. La Spada AR, Wilson EM, Lubahn DB, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77–79
  56. Thomas PS, Fraley GS, Damian V, et al. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Human Molecular Genetics. 2006;15:2225–2238
  57. Ogata T, Muroya K, Ishii T, et al. Undermasculinized genitalia in a boy with an abnormally expanded CAG repeat length in the androgen receptor gene. Clinical Endocrinology. 2001;54:835–838
  58. Lim HN, Chen H, McBride S, et al. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Human Molecular Genetics. 2000;9:829–834
  59. Mengual L, Oriola J, Ascaso C, et al. An increased CAG repeat length in the androgen receptor gene in azoospermic ICSI candidates. Journal of Andrology. 2003;24:279–284
  60. Zinn AR, Ramos P, Elder FF, et al. Androgen receptor CAGn repeat length influences phenotype of 47,XXY (Klinefelter) syndrome. The Journal of Clinical Endocrinology and Metabolism. 2005;90:5041–5046
  61. Tsujimoto Y, Takakuwa T, Takayama H, et al. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors. Prostate. 2004;58:283–290
  62. Santos ML, Sarkis AS, Nishimoto IN, et al. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population. Cancer Detection and Prevention. 2003;27:321–326
  63. Sawaya ME, Shalita AR. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne. Journal of Cutaneous Medicine and Surgery. 1998;3:9–15
  64. Zitzmann M, Nieschlag E. The CAG repeat polymorphism within the androgen receptor gene and maleness. International Journal of Andrology. 2003;26:76–83
  65. Ibanez L, Ong KK, Mongan N, et al. Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperndrogenism. The Journal of Clinical Endocrinology and Metabolism. 2003;88:3333–3338
  66. Gao T, Marcelli M, McPhaul MJ. Transcriptional activation and transient expression of the human androgen receptor. The Journal of Steroid Biochemistry and Molecular Biology. 1996;59:9–20
  67. Aschim EL, Nordenskjold A, Giwercman A, et al. Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. The Journal of Clinical Endocrinology and Metabolism. 2004;89:5105–5109
  68. Werner R, Holterhus PM, Binder G, et al. The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3515–3520
  69. Papadimitriou DT, Linglart A, Morel Y, et al. Puberty in subjects with complete androgen insensitivity syndrome. Hormone Research. 2006;65:126–131
  70. Melo KF, Mendonca BB, Billerbeck AE, et al. Clinical, hormonal, behavioural, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. The Journal of Clinical Endocrinology and Metabolism. 2003;88:3241–3250
  71. Sobel V, Schwarz B, Zhu YS, et al. Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3017–3023
  72. Savage MO, Lowe DG. Gonadal neoplasia and abnormal sexual differentiation. Clinical Endocrinology. 1990;32:519–533
  73. Cools M, Drop SL, Wolffenbuttel KP, et al. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocrine Reviews. 2006;27:468–484
  74. Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, et al. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS. 1998;106:198–204
  75. Almstrup K, Sonne SB, Hoei-Hansen CE, et al. From embryonic stem cells to testicular germ cell cancer – should we be concerned?. International Journal of Andrology. 2006;29:211–218
  76. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Human Reproduction Update. 2006;12:303–323
  77. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction (Oxford, England). 2001;16:972–978
  78. Manuel M, Katayama PK, Jones HW. The age of occurrence of gonadal tumours in intersex patients with a Y chromosome. American Journal of Obstetrics and Gynecology. 1976;124:293–300
  79. Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. International Journal of Gynecological Pathology. 1991;10:126–144
  80. Hannema SE, Scott IS, Rajpert-De Meyts E, et al. Testicular development in the complete androgen insensitivity syndrome. The Journal of Pathology. 2006;208:518–527
  81. Yalinkaya A, Yayla M. Laparoscopy-assisted transinguinal extracorporeal gonadectomy in six patients with androgen insensitivity syndrome. Fertility and Sterility. 2003;80:429–433
  82. Ahmed SF, Khwaja O, Hughes IA. The role of a clinical score in the assessment of ambiguous genitalia. BJU International. 2000;85:120–124
  83. Conn J, Gillam L, Conway GS. Revealing the diagnosis of androgen insensitivity syndrome in adulthood. BMJ (Clinical Research ed.). 2005;331:628–630
  84. Cools M, van Aerde K, Kersemaekers AM, et al. Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. The Journal of Clinical Endocrinology and Metabolism. 2005;90:5295–5303
  85. Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, et al. Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Annals of Oncology. 2005;16:863–868
  86. Poujol N, Lobaccaro JM, Chiche L, et al. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer. Molecular and Cellular Endocrinology. 1997;130:43–51
  87. MacLean HE, Brown RW, Beilin J, et al. Increased frequency of long androgen receptor CAG repeats in male breast cancers. Breast Cancer Research and Treatment. 2004;88:239–246
  88. Ahmed SF, Cheng A, Dovey L, et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. The Journal of Clinical Endocrinology and Metabolism. 2000;85:658–665
  89. Morel Y, Rey R, Teinturier C, et al. Aetiological diagnosis of male sex ambiguity: a collaborative study. European Journal of Pediatrics. 2002;161:49–59
  90. Hughes IA, Northstone K, Golding J ALSPAC Study Team. Reduced birth weight in boys with hypospadias: an index of androgen dysfunction?. Archives of Disease in Childhood. Fetal and Neonatal Edition. 2002;87:F150–F151
  91. Main KM, Jensen RB, Asklund C, et al. Low birth weight and male reproductive function. Hormone Research. 2006;65:116–122
  92. Migeon CJ, Wisniewski AB, Gearhart JP, et al. Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics. 2002;110:e31
  93. Bouvattier C, Mignot B, Lefevre H, et al. Impaired sexual activity in male adults with partial androgen insensitivity. The Journal of Clinical Endocrinology and Metabolism. 2006;91:3310–3315
  94. Hines M, Ahmed SF, Hughes IA. Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Archives of Sexual Behavior. 2003;32:93–101
  95. Wisniewski AB, Migeon CJ, Meyer-Bahlburg HF, et al. Complete androgen insensitivity syndrome: long-term medical, surgical and psychosexual outcome. The Journal of Clinical Endocrinology and Metabolism. 2000;85:2664–2669
  96. Ong YC, Wong HB, Adaikan G, et al. Directed pharmacological therapy of ambiguous genitalia due to an androgen receptor gene mutation. Lancet. 1999;354:1444–1445
  97. Loy CJ, Yong EL. Sex, infertility and the molecular biology of the androgen receptor. Current Opinion in Obstetrics & Gynecology. 2001;13:315–321
  98. Chu J, Zhang R, Zhao Z, et al. Male fertility is compatible with an Arg(840)Cys substitution in the AR in a large Chinese family affected with divergent phenotypes of AR insensitivity syndrome. The Journal of Clinical Endocrinology and Metabolism. 2002;87:347–351
  99. Weidemann W, Peters B, Romalo G, et al. Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the deoxyribonucleic acid-binding domain of the androgen receptor. The Journal of Clinical Endocrinology and Metabolism. 1998;83:1173–1176
  100. Gottlieb B, Beitel LK, Trifiro MA. Androgen Insensitivity Syndrome. Gene Reviews. 2006;http://www.geneclinics.orgLast updated 19 Sept 2006
  101. Warne G. Support groups for CAH and AIS. Endocrinologist. 2003;13:175–178
  102. McLaughlin J. Exploring diagnostic processes: social science perspectives. Archives of Disease in Childhood. 2005;90:284–287

PII: S1521-690X(06)00087-X

doi: 10.1016/j.beem.2006.11.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 4 , Pages 577-598 , December 2006

Article Tools

* Image Usage & Resolution